(Q46032907)

18 December 2017

title

Predicting response of ADHD symptoms to methylphenidate treatment based on comorbid anxiety. (English)

1 reference

18 December 2017

author name string

Brittany Blouin

1

1 reference

18 December 2017

Cindy Maddeaux

2

1 reference

18 December 2017

Jill Stanley Firestone

3

1 reference

18 December 2017

Judy van Stralen

4

1 reference

18 December 2017

publication date

1 January 2010

1 reference

18 December 2017

Journal of Attention Disorders

published in

1 reference

18 December 2017

volume

13

1 reference

18 December 2017

issue

4

1 reference

18 December 2017

page(s)

414-419

1 reference

18 December 2017

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

Correlates of ADHD among children in pediatric and psychiatric clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

The empirical status of cognitive-behavioral therapy: A review of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

Effect of anxiety on cognition, behavior, and stimulant response in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054708326269

21 January 2018

Identifiers

DOI

10.1177/1087054708326269

1 reference

18 December 2017

1 reference

18 December 2017